Topic: Oral Cancer

Health experts are pushing for increased HPV vaccination rates among 11 and 12-year-olds, claiming the vaccine is most effective before any sexual exposure. A report on NPR suggested the vaccine prevents "cancer of the penis," though critics point out that the primary medical focus has traditionally been on cervical and throat cancers. The aggressive marketing of the vaccine to young children is viewed by some as an effort to reestablish medical authority over parental concerns.

A flight attendant donor offers "extra peanuts" and upgrades, leading to a discussion on old habits. A dentist donor shares a story about the rise of HPV-related oral cancers. The segment includes nostalgia for John C. Dvorak’s columns in PC Magazine and Adam Curry’s MTV era.

A BBC documentary featuring an actress discussing the link between HPV and oral sex is critiqued for being a propaganda tool for the Gardasil vaccine. The hosts argue that the media is using fear of cancer to drive vaccination rates while ignoring potential side effects.

The UK is reportedly preparing to roll out the HPV vaccine for boys, accompanied by PR campaigns linking oral sex to throat cancer. The hosts view this as a marketing tactic for Gardasil. Additionally, a study claiming that 38.2% of the European Union population suffers from mental health problems is discussed as a precursor to increased pharmaceutical intervention.

Actress Jamie Winstone hosted a BBC documentary claiming one can "catch cancer" through oral sex via the HPV virus. The segment is criticized as a paid propaganda piece for the pharmaceutical industry to expand the market for the Gardasil vaccine to boys. The hosts describe the documentary as a "sales job" designed to get taxpayers to fund expensive, unnecessary shots.

A new study in the New England Journal of Medicine links a rise in head and neck cancers to HPV infections caused by oral sex. The hosts suggest this research is being used to push the Gardasil vaccine on both boys and girls. They express skepticism about the timing of the study and its potential funding from pharmaceutical companies.